タウロケノデオキシコール酸
- 関
- taurochenodeoxycholate
WordNet
- street name for lysergic acid diethylamide (同)back breaker, battery-acid, dose, dot, Elvis, loony toons, Lucy in the sky with diamonds, pane, superman, window pane, Zen
- any of various water-soluble compounds having a sour taste and capable of turning litmus red and reacting with a base to form a salt
- having the characteristics of an acid; "an acid reaction"
PrepTutorEJDIC
- 酸性の / 酸味のある,すっぱい(sour) / (言葉・態度などが)厳しい,しんらつな / 酸 / すっぱいもの / 《俗》=LSD
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/09/04 00:54:57」(JST)
[Wiki en表示]
Taurochenodeoxycholic acid
|
Names |
IUPAC name
-[4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid
|
Other names
12-Deoxycholyltaurine; 12-Desoxycholyltaurine; Chenodeoxycholyltaurine; Chenyltaurine
|
Identifiers |
CAS Number
|
516-35-8 N |
ChEBI |
CHEBI:16525 Y |
ChEMBL |
ChEMBL185878 Y |
ChemSpider |
343282 Y |
IUPHAR/BPS
|
4747 |
Jmol 3D model |
Interactive image |
PubChem |
387316 |
InChI
-
InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22-,24+,25+,26-/m1/s1 Y
Key: BHTRKEVKTKCXOH-BJLOMENOSA-N Y
-
InChI=1/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22-,24+,25+,26-/m1/s1
Key: BHTRKEVKTKCXOH-BJLOMENOBE
|
SMILES
-
O=S(=O)(O)CCNC(=O)CC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]4[C@H]2[C@H](O)C[C@@H]3C[C@H](O)CC[C@@]34C)C
|
Properties |
Chemical formula
|
C26H45NO6S |
Molar mass |
499.71 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
N verify (what is YN ?) |
Infobox references |
|
|
Taurochenodeoxycholic acid is a bile acid formed in the liver of most species, including humans, by conjugation of chenodeoxycholic acid with taurine. It is secreted into bile and then into intestine. It is usually ionized at physiologic pH, although it can be crystallized as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed by active transport in the terminal ileum. It is used as a cholagogue and choleretic.
See also
- Tauroursodeoxycholic acid, an epimer
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Cytotoxic bile acids, but not cytoprotective species, inhibit the ordering effect of cholesterol in model membranes at physiologically active concentrations.
- Mello-Vieira J, Sousa T, Coutinho A, Fedorov A, Lucas SD, Moreira R, Castro RE, Rodrigues CM, Prieto M, Fernandes F.SourceCentro de Química-Física Molecular and Institute of Nanoscience and Nanotechnology, IST, UTL, Lisbon, Portugal.
- Biochimica et biophysica acta.Biochim Biophys Acta.2013 Sep;1828(9):2152-63. doi: 10.1016/j.bbamem.2013.05.021. Epub 2013 Jun 5.
- Submillimolar concentrations of cytotoxic bile acids (BAs) induce cell death via apoptosis. On the other hand, several cytoprotective BAs were shown to prevent apoptosis in the same concentration range. Still, the mechanisms by which BAs trigger these opposite signaling effects remain unclear. This
- PMID 23747364
- Progressive stages of mitochondrial destruction caused by cell toxic bile salts.
- Schulz S, Schmitt S, Wimmer R, Aichler M, Eisenhofer S, Lichtmannegger J, Eberhagen C, Artmann R, Tookos F, Walch A, Krappmann D, Brenner C, Rust C, Zischka H.SourceInstitute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, D-85764 Neuherberg, Germany.
- Biochimica et biophysica acta.Biochim Biophys Acta.2013 Sep;1828(9):2121-33. doi: 10.1016/j.bbamem.2013.05.007. Epub 2013 May 17.
- The cell-toxic bile salt glycochenodeoxycholic acid (GCDCA) and taurochenodeoxycholic acid (TCDCA) are responsible for hepatocyte demise in cholestatic liver diseases, while tauroursodeoxycholic acid (TUDCA) is regarded hepatoprotective. We demonstrate the direct mitochondrio-toxicity of bile salts
- PMID 23685124
- Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
- Vaquero J, Monte MJ, Dominguez M, Muntané J, Marin JJ.SourceLaboratory of Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.
- Biochemical pharmacology.Biochem Pharmacol.2013 Aug 6. pii: S0006-2952(13)00458-9. doi: 10.1016/j.bcp.2013.07.022. [Epub ahead of print]
- The farnesoid X receptor (FXR) is a key sensor in bile acid homeostasis. Although four human FXR isoforms have been identified, the physiological role of this diversity is poorly understood. Here we investigated their subcellular localization, agonist sensitivity and response of target genes. Measur
- PMID 23928191
Japanese Journal
- Antibacterial Drug Treatment Increases Intestinal Bile Acid Absorption via Elevated Levels of Ileal Apical Sodium-Dependent Bile Acid Transporter but Not Organic Solute Transporter α Protein
- , , [他], ,
- Biological and Pharmaceutical Bulletin 38(3), 493-496, 2015
- … Antibacterial drug treatment increases the bile acid pool size and hepatic bile acid concentration through the elevation of hepatic bile acid synthesis. … However, the involvement of intestinal bile acid absorption in the increased bile acid pool size remains unclear. …
- NAID 130004872272
- Antibacterial drug treatment increases intestinal bile acid absorption via elevated levels of ileal apical sodium-dependent bile acid transporter but not organic solute transporter α protein
- , , , ,
- Biological and Pharmaceutical Bulletin advpub(0), 2014
- … Antibacterial drug treatment increases the bile acid pool size and hepatic bile acid concentration through the elevation of hepatic bile acid synthesis. … However, the involvement of intestinal bile acid absorption in the increased bile acid pool size remains unclear. …
- NAID 130004872289
- Strain Differences in Deconjugation of Bile Acids in Bifidobacterium pseudocatenulatum Isolates
- , , , , , , , ,
- Bioscience and microflora 23(2), 93-98, 2004-04-01
- … Six isolates of bifidobacteria with higher tolerance to 4.0% of bile were further evaluated for their ability to deconjugate different types of bile acids namely taurocholic acid (TC), glycocholic acid (GC), taurochenodeoxycholic acid (TCDC), glycochenodeoxycholic acid (GCDC), taurodeoxycholic acid (TDC), and glycodeoxycholic acid (GDC). …
- NAID 10027995027
Related Links
- Taurochenodeoxycholic acid is a bile acidformed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. It acts as detergent to solubilise fats in the small intestine and is itself absorbed. It is used as ...
- Buy Taurochenodeoxycholic-[2,2,4,4-d4] Acid, a biochemical for proteomics research, from Santa Cruz. Molecular Formula: C26H41D4NO6S, MW: 503.73 ... Taurochenodeoxycholic-[2,2,4,4-d4] Acid is a used as a method for the ...
★リンクテーブル★
[★]
タウロケノデオキシコール酸
- 関
- taurochenodeoxycholic acid
[★]
- 英
- taurochenodeoxycholic acid、taurochenodeoxycholate